Integrated Nanotherapeutics Inc Intis A Biotechnology Company Based In Burnabybritish Columbiacanadafounded In 2015The Company Specializes In Nanotechnology Driven Drug Delivery And Immune Tolerance Therapiesfocusing On Unmet Medical Needs In Cancer And Autoimmune Diseasesincluding Type 1 Diabetes Int Develops Lipid Nanoparticleslnpsthat Can Deliver Multiple Drug Modalities To Target Tissuesenhancing Drug Safety And Efficacytheir Proprietary Lnp Platform Allows For The Co Delivery Of Mrna Encoded Antigens And Immunomodulatorsaiming To Retrain The Immune System And Address Autoimmune Conditionsthe Company Is Advancing A Therapeutic Pipeline With A Lead Candidate Targeting Type 1 Diabetes Int Collaborates With Organizations Like Breakthrough T1D And Has Received Funding To Support Its Innovative Approaches In Autoimmune Disease Treatmentthe Company Operates At An Incubator Accelerator Stage And Has A Team Of Approximately 11 To 50 Employees
No conferences found for this company.
| Company Name | Nanotherapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
